Covered recipient · General Payments record
JOANNE P MCALVANY
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$2,853.63
- Reported across 135 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $721.56 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $281.23 | 14 |
| LEO Pharma Inc. | $177.56 | 9 |
| PFIZER INC. | $51.80 | 2 |
| Lilly USA, LLC | $51.07 | 2 |
| GENZYME CORPORATION | $30.78 | 1 |
| Arcutis Biotherapeutics, Inc. | $30.32 | 1 |
| Amgen Inc. | $29.90 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $27.17 | 1 |
| Janssen Biotech, Inc. | $21.15 | 1 |
| Incyte Corporation | $20.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.35 | 01/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104992895 | CMS |
| ABBVIE INC. | $13.46 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104992897 | CMS |
| ABBVIE INC. | $26.88 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104992899 | CMS |
| ABBVIE INC. | $18.02 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104992901 | CMS |
| ABBVIE INC. | $1.70 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104992903 | CMS |
| ABBVIE INC. | $24.36 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104992905 | CMS |
| ABBVIE INC. | $21.67 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104992907 | CMS |
| ABBVIE INC. | $33.72 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104992909 | CMS |
| ABBVIE INC. | $24.10 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104992911 | CMS |
| ABBVIE INC. | $24.56 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104992913 | CMS |
| ABBVIE INC. | $18.11 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104992915 | CMS |
| ABBVIE INC. | $20.81 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104992917 | CMS |
| ABBVIE INC. | $25.42 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104992919 | CMS |
| ABBVIE INC. | $16.07 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104992921 | CMS |
| Amgen Inc. | $29.90 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117322040 | CMS |
| Arcutis Biotherapeutics, Inc. | $30.32 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121054155 | CMS |
| GENZYME CORPORATION | $30.78 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139600348 | CMS |
| Incyte Corporation | $20.58 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141256863 | CMS |
| Janssen Biotech, Inc. | $21.15 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078536155 | CMS |
| LEO Pharma Inc. | $22.05 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152642147 | CMS |
| LEO Pharma Inc. | $20.15 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152642149 | CMS |
| LEO Pharma Inc. | $26.89 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152642151 | CMS |
| LEO Pharma Inc. | $18.02 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152642153 | CMS |
| LEO Pharma Inc. | $14.82 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152642155 | CMS |
| LEO Pharma Inc. | $18.81 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152642157 | CMS |
| LEO Pharma Inc. | $21.26 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152642159 | CMS |
| LEO Pharma Inc. | $5.97 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152642161 | CMS |
| LEO Pharma Inc. | $29.59 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152642163 | CMS |
| Lilly USA, LLC | $25.01 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135065231 | CMS |
| Lilly USA, LLC | $26.06 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135065229 | CMS |
| Novartis Pharmaceuticals Corporation | $27.17 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087048016 | CMS |
| PFIZER INC. | $25.18 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131279834 | CMS |
| PFIZER INC. | $26.62 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131692438 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.